Trisha is our Chief Financial Officer. She has a strong background in healthcare finance and business operations that stretches back more than 15 years, across multiple companies. Most recently she served as the Senior Vice President of Finance at Seragon Pharmaceuticals, a private biotechnology company focused on developing selective estrogen receptor degraders targeting hormone dependent cancers, which was acquired by Genentech. Before that she was Vice President of Finance at Aragon Pharmaceuticals, a discovery-stage small molecule company focused on therapeutics for the treatment of hormone resistant cancers, which was acquired by Johnson and Johnson. Previously, she worked in various senior financial management roles at Zogenix, a pharmaceutical company developing and commercializing innovative central nervous system therapies. Trisha spent five years with the public accounting firm Deloitte. She holds a B.S. in accounting from the University of San Diego and is a certified public accountant in the state of California.